Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
CereCore has joined Oracle's enhanced partner program to strengthen its support for healthcare organizations using Oracle Health platforms. The partnership enables CereCore to expand its capabilities in application management, optimization, and IT infrastructure services.
Supreme Group has appointed Olly Johnston as Executive Vice President of Platform Growth and Transformation to lead strategic initiatives across healthcare and life sciences marketing.
Conexiant has launched MDspire, an AI-powered platform that curates and synthesizes medical information for physicians and researchers, combining retrieval-augmented generation with expert review to ensure accuracy.
PureHealth reported AED 20.1 billion in revenue and AED 1.55 billion in net profit for the first nine months of 2025, reflecting growth across its healthcare and insurance operations.
A new report from Silicon Valley Bank reveals that AI-enabled provider operations have attracted the majority of Healthtech investment in 2025, accounting for 44% of total funding and 73% of mega-deals.
ABK Biomedical has secured $35 million in an oversubscribed Series D funding round led by J.P. Morgan Life Sciences Private Capital, with participation from existing investors. The funds will support clinical operations, commercialization of Eye90 microspheres, and expansion of manufacturing capabilities.
GT Biopharma, IDEAYA Biosciences, Zymeworks, and Regeneron Pharmaceuticals have each reported progress in oncology trials and approvals, highlighting continued momentum in biomarker-driven cancer treatments.
The Critical Path Institute has launched the Critical Path Disease Modeling Coalition to develop regulatory-grade models for pediatric inflammatory bowel disease, starting from its European hub.
The IISc Foundation and IndusSetu Global Foundation have signed an MoU to collaborate on medical research, translational science, and equitable healthcare across India and the US.
EXoPERT has joined Johnson & Johnson’s global incubator network, JLABS TMC, to accelerate development of its AI-enhanced exosome-based liquid biopsy platform for early cancer detection.
Expanse Medical announced it will open a new facility in Providence, Rhode Island, supported by the Rhode Island Life Science Hub, to accelerate East Coast partnerships and launch Valorian Medical Technologies, a men’s health-focused venture.
The RNA Horizons Therapeutics Symposium 2025 gathered researchers and biotech leaders in Palermo to discuss advances in RNA delivery, stability, and clinical translation, with the next event scheduled for Munich in 2026.
Scientist.com co-founder and Chief Technology Officer Chris Petersen has been awarded the 2025 Michael R. Saul CTO of the Year by 7CTOs, recognizing his leadership in AI-driven research innovation.
The National Health Council has launched PXI: Patient Experience + Innovation Center, a national initiative to ensure patients and caregivers are central to the development and use of AI and digital health technologies.
Akkodis announced successful AI implementations across life sciences, banking, and IT operations, showcasing measurable efficiency gains and large-scale workforce upskilling efforts.
Anthill has launched Anthill Cloud, a new platform combining AI, modular content, and omnichannel engagement to streamline content creation and improve healthcare professional communication in the pharmaceutical industry.
ACTO Technologies has introduced ACTOverse, a digital partner marketplace designed to integrate content, data, and service solutions with its AI-driven field excellence platform. The launch was announced at the Veeva Commercial Summit Europe.
Geeks360 has introduced its AI Enterprise Growth Solution, a new framework designed to help healthcare organizations connect marketing and operational systems to improve efficiency and scalability.
At the 2025 Sustainability Global Leaders Conference in Shanghai, Fosun International Co-Chairman Wang Qunbin outlined the company's innovation-driven globalization strategy, emphasizing breakthroughs in biopharmaceuticals, AI collaborations, and sustainable healthcare initiatives.
Healthcare Triangle has signed a non-binding letter of intent to acquire Spain-based Teyame.AI, aiming to create an integrated AI-driven global patient engagement platform projected to add $34 million in revenue for fiscal year 2025.
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
